Product Images Relafen

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Relafen NDC 73684-101 by Blucrest Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - relafen 01

Chemical Structure - relafen 01

Chemical Structure - relafen 02

Chemical Structure - relafen 02

Principal Display Panel - 750 mg Tablet Bottle Label - relafen 03

Principal Display Panel - 750 mg Tablet Bottle Label - relafen 03

This text is a medicine label with the name "RELAFEN", containing 750mg nabumetone tablets. It also includes instructions to the pharmacist to dispense with a medication guide separately provided. The pack has 30 tablets and details on usual adult dosage are given. Storage instructions are also provided, with a note to keep the medicine out of reach of children. The manufacturer is listed as Bluest Pharmaceuticals, LLC.*

Principal Display Panel - 500 mg Tablet Bottle Label - relafen 04

Principal Display Panel - 500 mg Tablet Bottle Label - relafen 04

Drug NDC 73684-100-30 is a package of 30 tablets of Relafen (Nabumefone Tablets, USP) with each table containing 500mg of nabumetone. The package comes with a medication guide and the usual adult dosage should be followed as provided in the package insert. The medication should be stored in a cool and dry place at 20°C to 25°C (66°F to 77°F). It is important to keep the medication out of reach of children. This product is manufactured in Hazket and distributed by bcrestpama.com.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.